Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases

Abstract Aims The role and selection of antithrombotic therapy to improve limb outcomes in chronic lower extremity artery disease (LEAD) is still debated. We conducted a meta-analysis to examine the efficacy and safety of antithrombotic and more intense antithrombotic therapy on limb outcomes and li...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal. Cardiovascular pharmacotherapy 2020-04, Vol.6 (2), p.86-93
Hauptverfasser:	Savarese, Gianluigi, Reiner, Martin F, Uijl, Alicia, D’Amario, Domenico, Agewall, Stefan, Atar, Dan, Baumgartner, Iris, Borghi, Claudio, De Carlo, Marco, Drexel, Heinz, Kaski, Juan Carlos, Kjeldsen, Keld P, Kucher, Nils, Lund, Lars H, Niessner, Alexander, Semb, Anne Grete, Schmidt, Thomas A, Sulzgruber, Patrick, Tamargo, Juan, Vitale, Cristiana, Wassmann, Sven, Aboyans, Victor, Lewis, Basil S
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Aged Amputation Amputation, Surgical Analysis Anticoagulants Anticoagulants (Medicine) Anticoagulants - administration & dosage Anticoagulants - adverse effects Blood circulation disorders Cardiology Cardiovascular agents Chronic Disease Coronary vessels Drug therapy Dual Anti-Platelet Therapy Female Fibrinolytic Agents - administration & dosage Fibrinolytic Agents - adverse effects Heart attack Hemorrhage - chemically induced Humans Limb Salvage Lower Extremity - blood supply Male Medical research Medicin och hälsovetenskap Medicine, Experimental Meta-analysis Middle Aged Peripheral Arterial Disease - diagnosis Peripheral Arterial Disease - drug therapy Peripheral Arterial Disease - mortality Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - adverse effects Randomized Controlled Trials as Topic Risk Assessment Risk Factors Stroke - mortality Stroke - prevention & control Systematic review Ticagrelor Time Factors Trade and professional associations Treatment Outcome Vein & artery diseases Working groups
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!